HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions.

Abstract
The purpose of this study was to evaluate the pattern of the expression of orotate phosphoribosyltransferase (OPRT) in several components of colorectal carcinoma (CRC). Fifty-six surgically-resected samples of CRC were subjected to immunohistochemistry with a polyclonal anti-OPRT antibody. Grading was performed independently for several components of CRC, including mucosal carcinoma lesions (n=56), infiltrative lesions (n=53), lymphovascularly invasive lesions (n=34) and metastatic lymph nodes (n=17). The expression of OPRT in mucosal carcinoma and infiltrative lesions correlated significantly only with the presence of lymphovascular invasion (p=0.0007 and <0.0001, respectively). The frequency of OPRT expression in mucosal carcinoma, infiltrative and lymphovascularly invasive lesions as well as metastatic lymph nodes was 32.1, 69.8, 88.2 and 88.8%, respectively. In addition, nuclear staining of OPRT was observed in metastatic lymph nodes and lymphovascularly invasive lesions. Our results suggest that OPRT is involved in the invasion and metastasis of CRC.
AuthorsYuichi Sanada, Kazuhiro Yoshida, Jun Hihara, Morihito Okada
JournalOncology reports (Oncol Rep) Vol. 20 Issue 5 Pg. 1005-11 (Nov 2008) ISSN: 1021-335X [Print] Greece
PMID18949394 (Publication Type: Journal Article)
Chemical References
  • CLDN1 protein, human
  • Claudin-1
  • Membrane Proteins
  • Orotate Phosphoribosyltransferase
Topics
  • Adenocarcinoma (enzymology, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Claudin-1
  • Colorectal Neoplasms (enzymology, pathology)
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphatic Metastasis (pathology)
  • Male
  • Membrane Proteins (biosynthesis)
  • Middle Aged
  • Orotate Phosphoribosyltransferase (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: